Litcius/Paper detail

Immunocompromised patients in the USA and UK should receive third dose of COVID-19 vaccine

Bryant Furlow

2021The Lancet Rheumatology13 citationsDOIOpen Access PDF

Topics & Concepts

ImmunogenicityFood and drug administrationMedicineCoronavirus disease 2019 (COVID-19)VaccinationDisease controlSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakVirologyFamily medicineImmunologyDiseaseEnvironmental healthInternal medicineInfectious disease (medical specialty)OutbreakImmune systemImmune responses and vaccinations
Immunocompromised patients in the USA and UK should receive third dose of COVID-19 vaccine | Litcius